GBT

Global Blood Therapeutics, Inc.
GBT

Overview Fund Activity
Delisted

GBT was delisted on the 4th of October, 2022.

Back to rankings

205 hedge funds and large institutions have $1.89B invested in Global Blood Therapeutics, Inc. in 2021 Q4 according to their latest regulatory filings, with 51 funds opening new positions, 61 increasing their positions, 64 reducing their positions, and 30 closing their positions.

Holders
205
Holders Change
+18
Holders Change %
+9.63%
% of All Funds
3.17%
Holding in Top 10
7
Holding in Top 10 Change
+4
Holding in Top 10 Change %
+133.33%
% of All Funds
0.11%
New
51
Increased
61
Reduced
64
Closed
30
Calls
$13.1M
Puts
$8.9M
Net Calls
+$4.25M
Net Calls Change
-$31.8M

Top Buyers

1
Citadel Advisors
1
Citadel Advisors
Florida
$49.3M
2
Fidelity Investments
2
Fidelity Investments
Massachusetts
$125M
3
APM
3
Avidity Partners Management
Texas
$25.2M
4
LGM
4
Logos Global Management
California
$22M
5
FFM
5
Fairmount Funds Management
Pennsylvania
$21.7M

Top Sellers

1
Point72 Asset Management
1
Point72 Asset Management
Connecticut
$5.37M
2
Franklin Resources
2
Franklin Resources
California
$17.9M
3
PA
3
Perceptive Advisors
New York
$101M
4
Janus Henderson Group
4
Janus Henderson Group
United Kingdom
$160M
5
CC
5
Casdin Capital
New York
$38.8M
Name Holding Trade Value Shares
Change 		Shares
Change %
EWA
226
Evolution Wealth Advisors
Florida
– -$4K -145 Closed
MHR
227
Matthew Hamilton Rosenberg
– -$3K -133 Closed
TWA
228
TCI Wealth Advisors
Arizona
– -$3K -120 Closed
LWM
229
Liberty Wealth Management
California
– -$2K -80 Closed
6 7 8 9
10